Viewing Study NCT00380367


Ignite Creation Date: 2025-12-25 @ 12:43 AM
Ignite Modification Date: 2025-12-27 @ 9:17 AM
Study NCT ID: NCT00380367
Status: COMPLETED
Last Update Posted: 2023-05-31
First Post: 2006-09-22
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Safety, Tolerability and Immunogenicity of HPV (Human Papilloma Virus) Vaccine in Healthy Females 9 to 15 Years of Age in India (V501-029)
Sponsor: Merck Sharp & Dohme LLC
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2007-05-03
Start Date Type: ACTUAL
Primary Completion Date: 2008-02-04
Primary Completion Date Type: ACTUAL
Completion Date: 2008-02-04
Completion Date Type: ACTUAL
First Submit Date: 2006-09-22
First Submit QC Date: None
Study First Post Date: 2006-09-26
Study First Post Date Type: ESTIMATED
Results First Submit Date: 2009-01-22
Results First Submit QC Date: None
Results First Post Date: 2009-04-14
Results First Post Date Type: ESTIMATED
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2023-05-02
Last Update Post Date: 2023-05-31
Last Update Post Date Type: ACTUAL